151. Cysteine conjugate toxicity in a human cell line: correlation with C-S lyase activity in human hepatic tissue
- Author
-
Ian S. Blagbrough, Lorraine D. Buckberry, and P. Nicholas Shaw
- Subjects
0301 basic medicine ,Cell Survival ,Health, Toxicology and Mutagenesis ,Lyases ,Mitochondria, Liver ,Biology ,Toxicology ,Xenobiotics ,03 medical and health sciences ,chemistry.chemical_compound ,0302 clinical medicine ,Tumor Cells, Cultured ,Humans ,Cysteine ,Mercapturic acid ,Lyase activity ,chemistry.chemical_classification ,030102 biochemistry & molecular biology ,General Medicine ,Glutathione ,Lyase ,Cytosol ,Carbon-Sulfur Lyases ,Enzyme ,Biochemistry ,chemistry ,Cell culture ,030220 oncology & carcinogenesis - Abstract
C-S lyase enzymes catalyse the generation of mutagenic and/or cytotoxic thiols from cysteine conjugated xenobiotics. These cysteine conjugates are produced subsequent to glutathione conjugations as a metabolic step in the mercapturic acid pathway, traditionally thought of as a pathway solely associated with detoxification. Human Chang liver (HCL) cells were challenged with a range of cysteine conjugates demonstrated to be substrates for human hepatic C-S lyases. The cellular toxicity of these compounds was determined and it was observed that the rank order of substrate toxicity obtained for the HCL cells followed the rank order of C-S lyase activity of the substrates in a freshly isolated mitochondrial fraction of human tissue. The presence of C-S lyase activity was also established in this cell line.
- Published
- 1993